Vitamin D Deficiency Is Associated with Advanced Liver Fibrosis and Impaired Fasting Glucose in Alcohol Use Disorder

Overview

Journal Nutrients

Date 2024 Apr 27

PMID 38674789

Authors

Paola Zuluaga

Julia Casado-Carbajo

Anna Hernandez-Rubio

Marvin Bueno-Velez

Carmen Garcia-Martin

Robert Muga

Daniel Fuster

Affiliations

Soon will be listed here.

Abstract

Background: Vitamin D deficiency is a risk factor for liver disease, insulin resistance, and beta cell dysfunction. Individuals with alcohol use disorder (AUD) have many comorbidities, with a heavy burden of liver disease and metabolic complications, including type 2 diabetes mellitus (T2DM).

Objective: We aimed to analyze the prevalence and associations of vitamin D deficiency in patients admitted for in-hospital treatment of AUD.

Methods: A cross-sectional study was conducted in patients consecutively admitted for the treatment of AUD between January 2017 and October 2023. Sociodemographic data, substance use characteristics, and blood parameters were available at admission. Vitamin D status was assessed through the serum concentrations of 25-hydroxyvitamin D [25(OH)D] levels using a direct competitive chemiluminescent immunoassay method. Deficiency of vitamin D was defined as a concentration less than 20 ng/mL; impaired fasting glucose (IFG) was defined by fasting blood glucose >100 mg/dL (5.6 mmol/L), and advanced liver fibrosis by an FIB-4 index >3.25.

Results: Two hundred and forty-three patients were included (75% male) with a mean age of 49 ± 10 years, mean BMI of 26.4 ± 7.3, mean alcohol consumption of 163 ± 81 g/day, and a mean duration of AUD of 18.1 ± 11.2 years. Mean 25(OH)D, fasting blood glucose, AST, ALT, and platelets were 14.4 ± 10.2 ng/mL, 103.4 ± 40.9 mg/dL, 55.1 ± 75.8 U/L, 44.8 ± 76.6 U/L, and 206.3 ± 84.8 × 10/L, respectively. The prevalence of vitamin D deficiency was 80.6%, and 41.1% of patients had levels less than 10 ng/mL. IFG was present in 32.3% of patients, and 20.5% had FIB-4 values >3.25. In the multivariable analysis, IFG (OR, 2.51; 95% CI: 1.02-6.17, = 0.04) and advanced liver fibrosis (OR, 4.27; 95% CI: 1.21-15.0, = 0.02) were the only factors associated with vitamin D deficiency.

Conclusions: Vitamin D deficiency was very prevalent in this series of patients with AUD and was associated with impaired fasting glucose and advanced liver fibrosis.

References

Bjelakovic G, Gluud L, Nikolova D, Whitfield K, Wetterslev J, Simonetti R . Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014; (1):CD007470. PMC: 11285307. DOI: 10.1002/14651858.CD007470.pub3. View

Banjac Baljak V, Mihajlovic G, Zivlak-Radulovic N, Nezic L, Miskovic M, Banjac V . Association between Vitamin D and Cognitive Deficiency in Alcohol Dependence. Healthcare (Basel). 2022; 10(9). PMC: 9498855. DOI: 10.3390/healthcare10091772. View

Triantos C, Aggeletopoulou I, Thomopoulos K, Mouzaki A . Vitamin D-Liver Disease Association: Biological Basis and Mechanisms of Action. Hepatology. 2021; 74(2):1065-1073. DOI: 10.1002/hep.31699. View

Szymczak-Pajor I, Drzewoski J, Sliwinska A . The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders. Int J Mol Sci. 2020; 21(18). PMC: 7554927. DOI: 10.3390/ijms21186644. View

. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2018; 70(1):172-193. PMC: 6657019. DOI: 10.1016/j.jhep.2018.06.024. View

Neupane S, Lien L, Hilberg T, Bramness J . Vitamin D deficiency in alcohol-use disorders and its relationship to comorbid major depression: a cross-sectional study of inpatients in Nepal. Drug Alcohol Depend. 2013; 133(2):480-5. DOI: 10.1016/j.drugalcdep.2013.07.006. View

Charoenngam N, Holick M . Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020; 12(7). PMC: 7400911. DOI: 10.3390/nu12072097. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Quintero-Platt G, Gonzalez-Reimers E, Martin-Gonzalez M, Jorge-Ripper C, Hernandez-Luis R, Abreu-Gonzalez P . Vitamin D, vascular calcification and mortality among alcoholics. Alcohol Alcohol. 2014; 50(1):18-23. DOI: 10.1093/alcalc/agu076. View

10.

Zhang P, Guo D, Xu B, Huang C, Yang S, Wang W . Association of Serum 25-Hydroxyvitamin D With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Prediabetes and Diabetes: Results From the UK Biobank Prospective Cohort Study. Diabetes Care. 2022; 45(5):1219-1229. DOI: 10.2337/dc21-2193. View

11.

Ravaioli F, Pivetti A, Di Marco L, Chrysanthi C, Frassanito G, Pambianco M . Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease. Int J Mol Sci. 2022; 23(16). PMC: 9409132. DOI: 10.3390/ijms23169016. View

12.

Saeki C, Kanai T, Ueda K, Nakano M, Oikawa T, Torisu Y . Prognostic significance of sarcopenia and severe vitamin D deficiency in patients with cirrhosis. JGH Open. 2023; 7(5):351-357. PMC: 10230111. DOI: 10.1002/jgh3.12900. View

13.

Glantz M, Bharat C, Degenhardt L, Sampson N, Scott K, Lim C . The epidemiology of alcohol use disorders cross-nationally: Findings from the World Mental Health Surveys. Addict Behav. 2019; 102:106128. PMC: 7416527. DOI: 10.1016/j.addbeh.2019.106128. View

14.

Sha S, Nguyen T, Kuznia S, Niedermaier T, Zhu A, Brenner H . Real-world evidence for the effectiveness of vitamin D supplementation in reduction of total and cause-specific mortality. J Intern Med. 2022; 293(3):384-397. DOI: 10.1111/joim.13578. View

15.

Manson J, Cook N, Lee I, Christen W, Bassuk S, Mora S . Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med. 2018; 380(1):33-44. PMC: 6425757. DOI: 10.1056/NEJMoa1809944. View

16.

Sterling R, Lissen E, Clumeck N, Sola R, Correa M, Montaner J . Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006; 43(6):1317-25. DOI: 10.1002/hep.21178. View

17.

Hernandez-Rubio A, Sanvisens A, Bolao F, Cachon-Suarez I, Garcia-Martin C, Short A . Prevalence and associations of metabolic syndrome in patients with alcohol use disorder. Sci Rep. 2022; 12(1):2625. PMC: 8850419. DOI: 10.1038/s41598-022-06010-3. View

18.

Lips P . Vitamin D physiology. Prog Biophys Mol Biol. 2006; 92(1):4-8. DOI: 10.1016/j.pbiomolbio.2006.02.016. View

19.

Keum N, Lee D, Greenwood D, Manson J, Giovannucci E . Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 2019; 30(5):733-743. PMC: 6821324. DOI: 10.1093/annonc/mdz059. View

20.

Chiu K, Chu A, Go V, Saad M . Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004; 79(5):820-5. DOI: 10.1093/ajcn/79.5.820. View